ArticleCHEST pulmonary2025

Prospective REALITI-A Study: 2-Year Real-World Benefits of Mepolizumab in Severe Asthma.

Cristiano Caruso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.